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OBJECTIVES: Hyperinfection or disseminated strongyloidiasis has been frequently reported after transplants
and is related to high mortality. This study aimed to screen for strongyloidiasis using serological diagnoses in
transplant candidates.
METHODS: An ELISA test was performed with filariform larvae of Strongyloides venezuelensis as a source
of antigen.
RESULTS: In the serum from transplant candidates, anti-Strongyloides IgG antibodies were detected in 35/150
(23.3%) samples by soluble fractions in phosphate buffered saline (PBS), 31/150 (20.7%) samples by soluble
fractions in Tris-HCl, 27/150 (18.0%) samples by membrane fractions in PBS and 22/150 (14.7%) samples by
membrane fractions in Tris-HCl.
CONCLUSIONS: The present results suggest the ELISA test, ideally using soluble fractions of filariform larvae
S. venezuelensis in PBS, as an additional strategy for the diagnosis of strongyloidiasis in transplant candidates.
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’ INTRODUCTION
The intestinal nematode Strongyloides stercoralis is respon-
sible for human strongyloidiasis, which is endemic in tropi-
cal and subtropical regions (1). This helminth may cause a
benign asymptomatic infection but may also result in more
severe complications, such as hyperinfection and dissemi-
nated disease, especially in immunocompromised patients
(2). Case reports of hyperinfection or disseminated strongy-
loidiasis have been frequently reported after solid-organ
transplants (3,4) and after transplantation of hematopoietic
cells (5) and are frequently associated with high mortality.
In this context, patients who are candidates for transplanta-
tion constitute an important group for S. stercoralis screening.
Early diagnosis and treatment of strongyloidiasis prior
to transplantation are important factors in minimizing the
probability of disease progression to more severe forms (6).
Therefore, the provision of specific and sensitive techniques
for the diagnosis of S. stercoralis infection in both donors and
recipients has therapeutic potential, especially in endemic
areas. The diagnosis of human strongyloidiasis is based on
the observation of S. stercoralis larvae in feces, particularly by
concentration or culture techniques (7). However, these para-
sitological techniques have low sensitivity, requiring multiple
samples to reach 100% sensitivity (8). Thus, serological techni-
ques have been used as alternative diagnostic tools, demon-
strating higher sensitivity than that of parasitological methods
(7). In a previous study by our group (9), IgG-ELISA using
filariform larvae antigens of Strongyloides venezuelensis showed
90-100% sensitivity and 92.4-98.4% specificity.
In recent years, the number of transplants worldwide has
increased considerably (10), implying that more transplant
candidates are at a risk of infectious diseases such as strongy-
loidiasis, especially its severe forms. This study aimed to
screen for strongyloidiasis by serological diagnosis in trans-
plant candidates using S. venezuelensis as a source of antigen.
’ MATERIAL AND METHODS
Serum samples
Serum samples (n=150) were obtained at Hospital das
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state of São Paulo, Brazil (HC-FMUSP), from patients who
signed informed consent. This study was integrated into
a larger study on S. stercoralis infection and was approved
by the Research Ethics Committee of HC-FMUSP (protocol
no. 0123/10). The transplant candidates were 10-60 years
of age from both genders and had underlying diseases
conferring some degree of immune dysfunction. All of the
patients included in the study had previously been admin-
istered parasitological tests [spontaneous sedimentation,
modified Baermann (11), and agar plate culture (12)]. Serum
samples were collected at the time of stool sample and
stored at -20oC.
Parasites and antigenic fractions
Antigenic fractions were obtained according to well-
standardized methods (9). Saline extracts of S. venezuelensis
filariform larvae (L3) were obtained from charcoal cultures
of feces from experimentally infected Rattus norvegicus
(Wistar), protocol (CPE-IMT 2011/126). L3 were resuspended
in phosphate buffered saline (PBS, 0.01 M, pH 7.2) or Tris-
HCl (25 mM, pH 7.5) containing protease inhibitors (Sigma-
Aldrich, St. Louis, MO, USA) and then disrupted in an ice
bath using a tissue homogenizer. The suspensions were cen-
trifuged at 12,400 g for 30 min at 4oC, and the supernatant
was collected. The soluble fractions prepared in PBS and Tris-
HCl were labeled ‘‘SS’’ and ‘‘TS,’’ respectively. The pellets
were resuspended in 1% SDS, or in buffer (7M urea, 2 M
thiourea, 2% CHAPS), and the supernatant was collected.
The membrane fractions prepared separately in PBS and
Tris-HCl were labeled ‘‘SM’’ and ‘‘TM,’’ respectively.
ELISA test
As described previously (9), polystyrene microplates were
coated with each of the antigenic fractions (SS, TS, SM, and
TM) at concentrations of 10 mg/mL in carbonate-bicarbonate
buffer (0.06 M, pH 9.6) prior to incubation overnight at 4oC.
After washing with PBS containing 0.05% Tween-20 and 3%
nonfat milk (PBS-TM), the microplates were incubated with
serum samples diluted 1:200 PBS-TM for 45 min at 37oC.
After washing with PBS-T, enzyme-conjugated goat anti-
human IgG (Fc specific)-peroxidase antibody (Sigma-Aldrich,
St. Louis, MO, USA) was added at a dilution of 1:30,000 in
PBS-TM and incubated for 45 min at 37oC. The assay was
developed by adding 3,30, 5,5- tetramethylbenzidine (TMB)
chromogen solution (Thermo Fischer Scientific, Waltham,
MA, USA) for 6 min. The reaction was interrupted with 2 N
H2SO4. Optical densities (ODs) were determined at 450 nm
using an ELISA reader (Thermo Fischer Scientific, Waltham,
MA, USA). Absorbance levels X0.309 for SS, X0.492 for TS,
X0.381 for SM, andX0.394 for TM were considered positive.
The cut-off values were determined by receiver operating
characteristic curve analysis using negative and other parasite
samples (n=72). The ELISA index (EI) was determined by
the ratio OD/cut-off, and RI values 41 were considered
positive.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
version 5.0 (GraphPad Software, La Jolla, USA). Detection
of IgG antibodies was analyzed by the Kruskal-Wallis test
followed by Dunn’s multiple comparison test. The concor-
dance was carried out by analysis of the kappa coefficient
(k). Statistical significance was set at po0.05.
’ RESULTS
Anti-Strongyloides IgG antibodies in serum from transplant
candidates were detected in 35/150 (23.3%) samples by SS,
31/150 (20.7%) samples by TS, 27/150 (18.0%) samples by
SM and 22/150 (14.7%) samples by TM (Figure 1). The para-
sitological diagnosis of the transplant candidates showed
that 15/150 (10%) of the patients’ stool samples contained
S. stercoralis larvae. Among the fifteen samples that tested
positive by the parasitological methods, five showed anti-
Strongyloides IgG antibodies detected by using SS and TS
antigenic fractions, and four showed anti-Strongyloides IgG
antibodies detected by using SM and TM antigenic frac-
tions. Four protozoan-positive samples, including Entamoeba
coli (n=3) and Endolimax nana (n=1), were observed, none
of which showed reactivity in the different antigenic
preparations.
When comparing the number of positive results identified
using different buffers, but the same type of fraction (soluble
or membrane), a moderate concordance was observed for
both TS and SS (k=0.567 (0.396–0.739)), and TM and SM
(k=0.433 (0.259–0.608)). When comparing soluble and mem-
brane fractions within the same buffer, a moderate concorda-
nce was observed for both TS and TM (k=0.567 (0.396–0.739))
and SS and SM (k=0.433 (0.259–0.608)). Similarly, when the
number of positive serum samples from patients was
analyzed by using soluble (TS and SS) or membrane (TM
and SM) fractions, kappa indices of 0.573 (0.414–0.732) and
0.781 (0.644–0.918), respectively, were observed, indicating
moderate and good concordance, respectively. Comparing
the results of the parasitological tests with those obtained by
the ELISA, none of the antigenic fractions demonstrated
superior performance.
’ DISCUSSION
Currently, there is an increased concern about transplanta-
tion and S. stercoralis infection, especially due to the increase
Figure 1 - Specific anti-Strongyloides IgG expressed as the ELISA
index (EI) for serum samples from transplant candidates using
S. venezuelensis antigenic fractions (SS, TS, SM and TM). The
dashed lines represent the positivity threshold (EI 41.0).
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in the number of transplant cases (13). Camargo et al. (14)
have stressed the need for new research for the rapid diag-
nosis and early treatment of solid-organ donors and recipients
before transplantation. Several studies evaluated extracts
from Strongyloides spp. suggesting that rodent species, such
as S. ratti and S. venezuelensis, can be used as good source of
antigens for the immunodiagnosis of human strongyloidiasis
(15,16). This study is the first to demonstrate the detection of
anti-Strongyloides IgG antibodies in candidates for transplan-
tation by an ELISA test using S. venezuelensis as an antigen.
Although the use of serology is a challenging proposal
for immunocompromised patients, many studies suggest
that it may be beneficial to this profile of patients (17,18).
In an ELISA using heterologous S. ratti antigen, 12.05% of
the samples showed positive results compared with 2.4%
positive results observed using parasitological techniques in
immunocompromised children (19). In a study by Schaffel
et al. (17) involving patients immunocompromised by mali-
gnant hematological disease, the performance of ELISA using
homologous antigen (18.8% tested positive) was superior to
that of parasitological methods (9.1% tested positive). In the
present study, ELISA showed a higher number of positive
results (14.7–20.7%) than did parasitological methods (10%),
independent of the antigenic preparation. Thus, the use of
the ELISA technique could be included for diagnostic scre-
ening in immunocompromised patients.
However, it is important to emphasize that antigen pre-
paration may interfere with serological test results (1). In the
present study, soluble fractions showed a higher number of
positive results than did membrane fractions. Although soluble
protein fractions are more frequently used in the immuno-
diagnosis of human strongyloidiasis (15,18), research also
indicates good performance using membrane fractions (9).
The limitations of the present study may be related to the
degree of immunosuppression, which may have compro-
mised the sensitivity of the ELISA test, leading to negative
ELISA results with positive parasitology. Although the
ELISA test used was a noncommercial method, our results
suggested its high positivity independent of the antigenic
preparation.
It is therefore important to emphasize that screening
should be performed with ELISA together with parasitolo-
gical analysis. Considering that transplant candidates are a
risk group for the occurrence of severe forms of strongyloi-
diasis, a positive ELISA result, independent of the antigenic
preparation, is a strong indication for specific treatment. In
conclusion, this study suggests the ELISA test, especially one
using SS fractions, as an additional technique for the
diagnosis of strongyloidiasis in transplant candidates.
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